Financing led by institutional investors, with participation from new investor Eli Lilly and CompanyInclusive of this investment, a total of $123 ...
-- Bruton’s tyrosine kinase (BTK) SH2 inhibitor reduced skin inflammation in a clinically-relevant model of chronic spontaneous urticaria (CSU) --BTK inhibition through the SH2 domain results in ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果